​

IQVIA (IQV) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

IQV Stock Forecast

IQVIA (IQV) stock forecast, based on 41 Wall Street analysts, predicts a 12-month average price target of $220.00, with a high of $265.00 and a low of $160.00. This represents a 43.37% increase from the last price of $153.45.

$150 $180 $210 $240 $270 $300 High: $265 Avg: $220 Low: $160 Last Closed Price: $153.45

IQV Stock Rating

IQVIA stock's rating consensus is Buy, based on 41 Wall Street analysts. The breakdown includes 1 Strong Buy (2.44%), 32 Buy (78.05%), 8 Hold (19.51%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 41 8 32 1 Strong Sell Sell Hold Buy Strong Buy

IQV Price Target Upside V Benchmarks

TypeNameUpside
StockIQVIA43.37%
SectorHealthcare Stocks 30.37%
IndustryDiagnostics & Research Stocks33.90%
IdeaSaaS Stocks List25.42%

Price Target Trends

1M3M12M
# Anlaysts1114
Avg Price Target$160.00$160.00$252.74
Last Closing Price$153.45$153.45$153.45
Upside/Downside4.27%4.27%64.71%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 255155--25
Mar, 257145--26
Feb, 257155--27
Jan, 257154--26
Dec, 247154--26
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 25, 2025Sidharth SahooHSBC$160.00$150.286.47%4.27%
Nov 04, 2024Jaliendra SinghTruist Financial$265.00$210.1926.08%72.69%
Oct 31, 2024Elizabeth AndersonEvercore ISI$235.00$205.8214.18%53.14%
Oct 29, 2024Sean DodgeRBC Capital$270.00$217.5424.12%75.95%
Oct 16, 2024Justin BowersDeutsche Bank$270.00$232.9815.89%75.95%
Oct 14, 2024Jamie ClarkRedburn Partners$276.00$229.2620.39%79.86%
Sep 20, 2024Eric ColdwellRobert W. Baird$256.00$244.624.65%66.83%
Aug 05, 2024Jonathan BlockStifel Nicolaus$175.38$236.24-25.76%14.29%
Jul 23, 2024Jailendra SinghTruist Financial$300.00$240.2724.86%95.50%
Jul 23, 2024Elizabeth AndersonEvercore ISI$270.00$239.5012.73%75.95%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Apr 25, 2025HSBCHolddowngrade
Feb 03, 2025BTIGBuyNeutraldowngrade
Dec 19, 2024StephensOverweightinitialise
Nov 01, 2024Cowen & Co.BuyBuyhold
Nov 01, 2024BTIGBuyBuyhold
Oct 29, 2024RBC CapitalOutperformOutperformhold
Oct 16, 2024Deutsche BankBuyBuyhold
Sep 04, 2024RBC CapitalOutperformUnderperforminitialise
Sep 03, 2024RBC CapitalOutperforminitialise
Jul 24, 2024JefferiesHolddowngrade

Financial Forecast

EPS Forecast

$0 $4 $8 $12 $16 $20 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.46$5.05$5.82$7.39$7.57----
Avg Forecast$6.31$8.91$10.15$10.19$11.12$11.92$13.28$14.73$16.44
High Forecast$6.43$9.08$10.36$10.21$11.17$12.16$15.49$16.25$16.73
Low Forecast$6.23$8.79$9.99$10.17$11.10$11.61$11.72$12.58$15.94
Surprise %-76.86%-43.32%-42.66%-27.48%-31.92%----

Revenue Forecast

$11B $13B $15B $16B $18B $20B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$11.36B$13.87B$14.41B$14.98B$15.40B----
Avg Forecast$11.20B$13.83B$14.38B$14.91B$15.38B$16.04B$17.01B$18.04B$19.49B
High Forecast$11.35B$14.02B$14.61B$14.92B$15.39B$16.21B$17.01B$18.06B$19.76B
Low Forecast$11.08B$13.68B$14.21B$14.90B$15.35B$15.68B$17.01B$18.02B$19.03B
Surprise %1.44%0.32%0.20%0.49%0.18%----

Net Income Forecast

$0 $700M $1B $2B $3B $4B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$279.00M$966.00M$1.09B$1.36B$1.37B----
Avg Forecast$268.05M$896.18M$1.17B$1.36B$2.07B$2.21B$2.54B$2.69B$3.06B
High Forecast$329.82M$1.08B$1.41B$1.63B$2.08B$2.27B$2.89B$3.03B$3.12B
Low Forecast$206.28M$716.94M$938.68M$1.09B$2.07B$2.16B$2.18B$2.34B$2.97B
Surprise %4.09%7.79%-7.02%--33.80%----

IQV Forecast FAQ

Is IQVIA stock a buy?

IQVIA stock has a consensus rating of Buy, based on 41 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 32 Buy, 8 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that IQVIA is a favorable investment for most analysts.

What is IQVIA's price target?

IQVIA's price target, set by 41 Wall Street analysts, averages $220 over the next 12 months. The price target range spans from $160 at the low end to $265 at the high end, suggesting a potential 43.37% change from the previous closing price of $153.45.

How does IQVIA stock forecast compare to its benchmarks?

IQVIA's stock forecast shows a 43.37% upside, outperforming the average forecast for the healthcare stocks sector (30.37%) and outperforming the diagnostics & research stocks industry (33.90%), leading the saas stocks list (25.42%) investment idea.

What is the breakdown of analyst ratings for IQVIA over the past three months?

  • April 2025: 20.00% Strong Buy, 60.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 26.92% Strong Buy, 53.85% Buy, 19.23% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 25.93% Strong Buy, 55.56% Buy, 18.52% Hold, 0% Sell, 0% Strong Sell.

What is IQVIA’s EPS forecast?

IQVIA's average annual EPS forecast for its fiscal year ending in December 2025 is $11.92, marking a 57.46% increase from the reported $7.57 in 2024. Estimates for the following years are $13.28 in 2026, $14.73 in 2027, and $16.44 in 2028.

What is IQVIA’s revenue forecast?

IQVIA's average annual revenue forecast for its fiscal year ending in December 2025 is $16.04B, reflecting a 4.09% increase from the reported $15.4B in 2024. The forecast for 2026 is $17.01B, followed by $18.04B for 2027, and $19.49B for 2028.

What is IQVIA’s net income forecast?

IQVIA's net income forecast for the fiscal year ending in December 2025 stands at $2.21B, representing an 61.26% increase from the reported $1.37B in 2024. Projections indicate $2.54B in 2026, $2.69B in 2027, and $3.06B in 2028.